Skip to main content
. 2008 Sep 7;2008:943614. doi: 10.1155/2008/943614

Figure 2.

Figure 2

Changes in plasma volume in PPARγ f/f and CD PPARγ knockout mice following rosiglitazone (RGZ) treatment (adapted from [28]). (a) Hematocrit (Hct) in PPARγ f/f and CD PPARγ knockout mice before and after RGZ treatment. (b) Plasma aldosterone levels in PPARγ f/f and CD PPARγ knockout mice following RGZ treatment. (c) Determination of plasma volume in PPARγ f/f and CD PPARγ KO mice by the Evans blue (EB) dye technique.